When robots are made out of modular units, their size, shape, and functionality can be modified to perform any number of ...

Diversity-generating retroelements (DGRs) are found in the genomes of microorganisms across the globe—from the arctic permafrost to Yellowstone's hot springs and the human gut. DGRs are able to ...

Yale researchers are sifting through a mosaic of cells in a living animal—both normal cells and mutated cells—to better ...

Most mutations which cause disease by swapping one amino acid out for another do so by making the protein less stable, according to a massive study of human protein variants published in the journal ...

The global proteinase K market is projected to grow from US$ 27.5 million in 2023 to US$ 43.9 million by 2033, at a CAGR of 4 ...

I recently watched an episode of one of my favourite TV shows, the Good Doctor. The episode revolved around how a man named Wyatt was rushed into the ER as he had a perforated valve and needed ...

There are plenty of questions out there about the potential dangers of AI. This story involving Google's Gemini AI certainly ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

The news cycle in 2024 was busy to say the least. Chaotic may be the more appropriate term, with an onslaught of election ...

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Relapsed Acute Myeloid Leukemia.

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome.